Logo image of LXU

LSB INDUSTRIES INC (LXU) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:LXU - US5021601043 - Common Stock

8.53 USD
0 (0%)
Last: 12/23/2025, 6:40:00 PM
8.53 USD
0 (0%)
After Hours: 12/23/2025, 6:40:00 PM
Fundamental Rating

4

Overall LXU gets a fundamental rating of 4 out of 10. We evaluated LXU against 84 industry peers in the Chemicals industry. LXU has an average financial health and profitability rating. LXU is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

LXU had positive earnings in the past year.
LXU had a positive operating cash flow in the past year.
In multiple years LXU reported negative net income over the last 5 years.
LXU had a positive operating cash flow in 4 of the past 5 years.
LXU Yearly Net Income VS EBIT VS OCF VS FCFLXU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

LXU's Return On Assets of -0.06% is in line compared to the rest of the industry. LXU outperforms 52.38% of its industry peers.
LXU has a Return On Equity (-0.13%) which is in line with its industry peers.
LXU has a Return On Invested Capital of 2.77%. This is comparable to the rest of the industry: LXU outperforms 45.24% of its industry peers.
The Average Return On Invested Capital over the past 3 years for LXU is in line with the industry average of 6.09%.
The 3 year average ROIC (7.85%) for LXU is well above the current ROIC(2.77%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -0.06%
ROE -0.13%
ROIC 2.77%
ROA(3y)5.51%
ROA(5y)-2.47%
ROE(3y)15.37%
ROE(5y)-5.05%
ROIC(3y)7.85%
ROIC(5y)N/A
LXU Yearly ROA, ROE, ROICLXU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

1.3 Margins

The Operating Margin of LXU (6.06%) is comparable to the rest of the industry.
LXU's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 12.46%, LXU is not doing good in the industry: 76.19% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of LXU has grown nicely.
Industry RankSector Rank
OM 6.06%
PM (TTM) N/A
GM 12.46%
OM growth 3Y-59.74%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-28.46%
GM growth 5Y46.21%
LXU Yearly Profit, Operating, Gross MarginsLXU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so LXU is destroying value.
Compared to 1 year ago, LXU has less shares outstanding
The number of shares outstanding for LXU has been increased compared to 5 years ago.
Compared to 1 year ago, LXU has an improved debt to assets ratio.
LXU Yearly Shares OutstandingLXU Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
LXU Yearly Total Debt VS Total AssetsLXU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

LXU has an Altman-Z score of 1.63. This is a bad value and indicates that LXU is not financially healthy and even has some risk of bankruptcy.
LXU's Altman-Z score of 1.63 is in line compared to the rest of the industry. LXU outperforms 44.05% of its industry peers.
LXU has a Debt/Equity ratio of 0.89. This is a neutral value indicating LXU is somewhat dependend on debt financing.
The Debt to Equity ratio of LXU (0.89) is worse than 60.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Altman-Z 1.63
ROIC/WACC0.26
WACC10.76%
LXU Yearly LT Debt VS Equity VS FCFLXU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M

2.3 Liquidity

LXU has a Current Ratio of 2.84. This indicates that LXU is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.84, LXU belongs to the top of the industry, outperforming 80.95% of the companies in the same industry.
LXU has a Quick Ratio of 2.28. This indicates that LXU is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.28, LXU belongs to the best of the industry, outperforming 84.52% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.84
Quick Ratio 2.28
LXU Yearly Current Assets VS Current LiabilitesLXU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 40.00% over the past year.
LXU shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.49%.
Measured over the past years, LXU shows a small growth in Revenue. The Revenue has been growing by 7.43% on average per year.
EPS 1Y (TTM)40%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%127.73%
Revenue 1Y (TTM)12.49%
Revenue growth 3Y-2.07%
Revenue growth 5Y7.43%
Sales Q2Q%42.31%

3.2 Future

The Earnings Per Share is expected to grow by 1.25% on average over the next years.
Based on estimates for the next years, LXU will show a small growth in Revenue. The Revenue will grow by 3.57% on average per year.
EPS Next Y-38.68%
EPS Next 2Y-22.85%
EPS Next 3Y-11.07%
EPS Next 5Y1.25%
Revenue Next Year19.77%
Revenue Next 2Y7.77%
Revenue Next 3Y7.46%
Revenue Next 5Y3.57%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
LXU Yearly Revenue VS EstimatesLXU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M
LXU Yearly EPS VS EstimatesLXU Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 17.41, LXU is valued on the expensive side.
LXU's Price/Earnings ratio is a bit cheaper when compared to the industry. LXU is cheaper than 60.71% of the companies in the same industry.
LXU's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.50.
With a Price/Forward Earnings ratio of 25.59, LXU can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of LXU is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of LXU to the average of the S&P500 Index (23.93), we can say LXU is valued inline with the index average.
Industry RankSector Rank
PE 17.41
Fwd PE 25.59
LXU Price Earnings VS Forward Price EarningsLXU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LXU indicates a somewhat cheap valuation: LXU is cheaper than 79.76% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.71
LXU Per share dataLXU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

A cheap valuation may be justified as LXU's earnings are expected to decrease with -11.07% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-22.85%
EPS Next 3Y-11.07%

0

5. Dividend

5.1 Amount

LXU does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

LSB INDUSTRIES INC

NYSE:LXU (12/23/2025, 6:40:00 PM)

After market: 8.53 0 (0%)

8.53

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)10-29 2025-10-29/amc
Earnings (Next)02-24 2026-02-24/amc
Inst Owners60.74%
Inst Owner Change2.25%
Ins Owners4.13%
Ins Owner Change-0.22%
Market Cap613.65M
Revenue(TTM)585.07M
Net Income(TTM)-668.00K
Analysts75
Price Target10.07 (18.05%)
Short Float %2.91%
Short Ratio3.48
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.51%
Min EPS beat(2)-33.99%
Max EPS beat(2)35.01%
EPS beat(4)3
Avg EPS beat(4)51.48%
Min EPS beat(4)-33.99%
Max EPS beat(4)135.15%
EPS beat(8)6
Avg EPS beat(8)53.34%
EPS beat(12)8
Avg EPS beat(12)28.4%
EPS beat(16)10
Avg EPS beat(16)40.69%
Revenue beat(2)1
Avg Revenue beat(2)5.1%
Min Revenue beat(2)-4.79%
Max Revenue beat(2)14.99%
Revenue beat(4)3
Avg Revenue beat(4)7.5%
Min Revenue beat(4)-4.79%
Max Revenue beat(4)14.99%
Revenue beat(8)6
Avg Revenue beat(8)5.82%
Revenue beat(12)9
Avg Revenue beat(12)3.98%
Revenue beat(16)12
Avg Revenue beat(16)4.06%
PT rev (1m)12.06%
PT rev (3m)12.06%
EPS NQ rev (1m)40%
EPS NQ rev (3m)6.06%
EPS NY rev (1m)-9.74%
EPS NY rev (3m)-23.6%
Revenue NQ rev (1m)-9.34%
Revenue NQ rev (3m)-4.66%
Revenue NY rev (1m)3.43%
Revenue NY rev (3m)4.46%
Valuation
Industry RankSector Rank
PE 17.41
Fwd PE 25.59
P/S 1.05
P/FCF N/A
P/OCF 7.52
P/B 1.22
P/tB 1.22
EV/EBITDA 6.71
EPS(TTM)0.49
EY5.74%
EPS(NY)0.33
Fwd EY3.91%
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)1.13
OCFY13.29%
SpS8.13
BVpS7.01
TBVpS7
PEG (NY)N/A
PEG (5Y)N/A
Graham Number8.79
Profitability
Industry RankSector Rank
ROA -0.06%
ROE -0.13%
ROCE 3.36%
ROIC 2.77%
ROICexc 3.23%
ROICexgc 3.23%
OM 6.06%
PM (TTM) N/A
GM 12.46%
FCFM N/A
ROA(3y)5.51%
ROA(5y)-2.47%
ROE(3y)15.37%
ROE(5y)-5.05%
ROIC(3y)7.85%
ROIC(5y)N/A
ROICexc(3y)11.08%
ROICexc(5y)N/A
ROICexgc(3y)11.1%
ROICexgc(5y)N/A
ROCE(3y)9.64%
ROCE(5y)N/A
ROICexgc growth 3Y-59.46%
ROICexgc growth 5YN/A
ROICexc growth 3Y-59.42%
ROICexc growth 5YN/A
OM growth 3Y-59.74%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-28.46%
GM growth 5Y46.21%
F-Score7
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Debt/EBITDA 3.83
Cap/Depr 103.35%
Cap/Sales 14.45%
Interest Coverage 1.15
Cash Conversion 69.57%
Profit Quality N/A
Current Ratio 2.84
Quick Ratio 2.28
Altman-Z 1.63
F-Score7
WACC10.76%
ROIC/WACC0.26
Cap/Depr(3y)96.58%
Cap/Depr(5y)76.59%
Cap/Sales(3y)11.38%
Cap/Sales(5y)9.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%127.73%
EPS Next Y-38.68%
EPS Next 2Y-22.85%
EPS Next 3Y-11.07%
EPS Next 5Y1.25%
Revenue 1Y (TTM)12.49%
Revenue growth 3Y-2.07%
Revenue growth 5Y7.43%
Sales Q2Q%42.31%
Revenue Next Year19.77%
Revenue Next 2Y7.77%
Revenue Next 3Y7.46%
Revenue Next 5Y3.57%
EBIT growth 1Y258.45%
EBIT growth 3Y-60.57%
EBIT growth 5YN/A
EBIT Next Year2325.63%
EBIT Next 3Y195.69%
EBIT Next 5Y92.24%
FCF growth 1Y-101.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-60.6%
OCF growth 3Y-0.4%
OCF growth 5Y110.4%

LSB INDUSTRIES INC / LXU FAQ

What is the fundamental rating for LXU stock?

ChartMill assigns a fundamental rating of 4 / 10 to LXU.


Can you provide the valuation status for LSB INDUSTRIES INC?

ChartMill assigns a valuation rating of 2 / 10 to LSB INDUSTRIES INC (LXU). This can be considered as Overvalued.


What is the profitability of LXU stock?

LSB INDUSTRIES INC (LXU) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for LXU stock?

The Price/Earnings (PE) ratio for LSB INDUSTRIES INC (LXU) is 17.41 and the Price/Book (PB) ratio is 1.22.


How financially healthy is LSB INDUSTRIES INC?

The financial health rating of LSB INDUSTRIES INC (LXU) is 5 / 10.